A multicenter, randomized, double blind, placebo controlled multiple dose study of the efficacy and safety of AS-3201 in patients with DSP (diabetic sensorimotor polyneuropathy)

Authors
Category Primary study
Registry of TrialsJapicCTI
Year 2007
INTERVENTION: Intervention name : AS‐3201 (ranirestat) Dosage And administration of the intervention : Oral CONDITION: Diabetic sensorimotor polyneuropathy PRIMARY OUTCOME: Efficacy: nerve conduction velocity, etc INCLUSION CRITERIA: Patients with DSP who satisfy the following inclusion criteria ‐ Patients who have DSP symptoms, signs and abnormal nerve conduction on the basis of pre‐defined criteria ‐ Patients aged 20 to 75 ‐ Outpatients etc. ‐ Patients with known non diabetic causes of neuropathic symptoms ‐ Patients with focal or entrapment neuropathy ‐ Patients with a history of epilepsy or serious head injury etc.
Epistemonikos ID: 46f61c4cb502ce4ec4f17befe2ea5569fb8f9cdf
First added on: Aug 21, 2024